Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective

@article{Papoian2015SecondaryPD,
  title={Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective},
  author={Thomas Papoian and Haw-Jyh Chiu and Ikram Elayan and Gowraganahalli Jagadeesh and Imran Khan and Adebayo A. Laniyonu and Cindy Li and Muriel Saulnier and Natalie Simpson and Baichun Yang},
  journal={Nature Reviews Drug Discovery},
  year={2015},
  volume={14},
  pages={294-294}
}
Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective 

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practices.

  • Journal of pharmacological and toxicological methods
  • 2018
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence

  • Toxicological sciences : an official journal of the Society of Toxicology
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-9 OF 9 REFERENCES

the use of in vitro pharmacological profiling

Bowes, J. et al. Reducing safety-related drug attrition
  • Nature Rev. Drug Discov. 11, 909–922
  • 2012

a discovery strategy to reduce attrition in development

Bass, A. S. et al. Exploratory drug safety
  • J. Pharmacol. Toxicol. Methods 60, 69–78
  • 2009

successes, threats, challenges and opportunities

J. P. Valentin, Hammond, T. Safety, secondary pharmacology
  • J. Pharmacol. Toxicol. Methods 58, 77–87
  • 2008

an essential tool for successful drug development

Whitebread, S. et al. In vitro safety pharmacology profiling
  • Drug Discov. Today 10, 1421–1433
  • 2005

The application of in vitro methods to safety pharmacology

Wakefield, D I.
  • Fundam. Clin. Pharmacol. 16,
  • 2002